Literature DB >> 15509624

Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.

Karolina Wosik1, Francesca Ruffini, Guillermina Almazan, André Olivier, Josephine Nalbantoglu, Jack P Antel.   

Abstract

Multiple sclerosis is an inflammatory disease of the CNS leading to the destruction of oligodendrocytes (OLs), myelin sheaths and axons. The mediators of tissue injury remain unknown. Glutamate, which can be released by activated immune cells or produced within the CNS, has been implicated as a potential mediator of tissue injury in multiple sclerosis. alpha-Amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) and kainate are highly toxic when added to rodent OL cultures. Using OLs derived from human adult surgical specimens, we investigated AMPA/kainate receptor expression and the effects of receptor stimulation on the viability of human OLs. We find that human adult OLs in vitro express low levels of ionotropic glutamate receptors and are resistant to excitotoxicity mediated by high and sustained doses of AMPA or kainate, even when receptor desensitization is blocked. In contrast, rat OLs show strong AMPA receptor expression and are susceptible to excitotoxicity, as previously demonstrated. Furthermore, we show in human brain sections that OLs do not express AMPA receptors in situ and that glial expression of AMPA receptors is limited to astrocytes. The apparent lack of glutamate receptor expression on human OLs and their resistance to AMPA/kainate toxicity should be considered when postulating mechanisms of tissue injury in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509624     DOI: 10.1093/brain/awh302

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes.

Authors:  Brandon A Miller; Fang Sun; Randolph N Christensen; Adam R Ferguson; Jacqueline C Bresnahan; Michael S Beattie
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

2.  Activation of sodium-dependent glutamate transporters regulates the morphological aspects of oligodendrocyte maturation via signaling through calcium/calmodulin-dependent kinase IIβ's actin-binding/-stabilizing domain.

Authors:  Zila Martinez-Lozada; Christopher T Waggener; Karam Kim; Shiping Zou; Pamela E Knapp; Yasunori Hayashi; Arturo Ortega; Babette Fuss
Journal:  Glia       Date:  2014-05-28       Impact factor: 7.452

Review 3.  Sodium-Calcium Exchangers of the SLC8 Family in Oligodendrocytes: Functional Properties in Health and Disease.

Authors:  Samantha A Spencer; Edna Suárez-Pozos; Miguel Escalante; Yu Par Myo; Babette Fuss
Journal:  Neurochem Res       Date:  2020-01-11       Impact factor: 3.996

Review 4.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

5.  Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.

Authors:  Veronique E Miron; Jeffery A Hall; Timothy E Kennedy; Betty Soliven; Jack P Antel
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

Review 6.  Glutamate receptors in neuroinflammatory demyelinating disease.

Authors:  Christopher Bolton; Carolyn Paul
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

7.  Developmental stage of oligodendrocytes determines their response to activated microglia in vitro.

Authors:  Brandon A Miller; Jeannine M Crum; C Amy Tovar; Adam R Ferguson; Jacqueline C Bresnahan; Michael S Beattie
Journal:  J Neuroinflammation       Date:  2007-11-26       Impact factor: 8.322

Review 8.  Iron chelation and multiple sclerosis.

Authors:  Kelsey J Weigel; Sharon G Lynch; Steven M LeVine
Journal:  ASN Neuro       Date:  2014-01-30       Impact factor: 4.146

9.  Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway.

Authors:  Issa P Bagayogo; Cheryl F Dreyfus
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

10.  Essential roles of plexin-B3+ oligodendrocyte precursor cells in the pathogenesis of Alzheimer's disease.

Authors:  Naomi Nihonmatsu-Kikuchi; Xiu-Jun Yu; Yoshiki Matsuda; Nobuyuki Ozawa; Taeko Ito; Kazuhito Satou; Tadashi Kaname; Yasushi Iwasaki; Akio Akagi; Mari Yoshida; Shuta Toru; Katsuiku Hirokawa; Akihiko Takashima; Masato Hasegawa; Toshiki Uchihara; Yoshitaka Tatebayashi
Journal:  Commun Biol       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.